Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06413745
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2024-05-09
Brief Title:
Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-04
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-09
First Submit QC Date:
May 13 2024
Study First Post Date:
2024-05-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-04
Last Update Post Date:
2024-07-08
Last Update Post Date Type:
ACTUAL